Merck’s Covid Pill Is Authorized for High-Risk Adults | New York Times

CEID Founding Director Dr. Nahid Bhadelia discusses the role of the newly-authorized COVID-19 pill from Merck.

“’Anything that keeps people out of the hospital, even incremental, has a role,’ said Dr. Nahid Bhadelia, director of the Center for Emerging Infectious Diseases Policy and Research at Boston University.”

Read the full article here